Approval · Notice of Compliance 12918 · 2011
ROSASOL: Notice of Compliance 12918
Issued October 7, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12918
- Date
- October 7, 2011
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update to reflect the two sunscreens as active ingredients
- Therapeutic class
- Anti-rosacea Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROSASOL | 02242919 | Cancelled Post Market |
Medicinal ingredients
- AVOBENZONE 20 MG per G
- METRONIDAZOLE 10 MG per G
- OCTINOXATE 75 MG per G